Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies
- 1 February 1996
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 86 (2) , 116-119
- https://doi.org/10.1016/0165-4608(95)00207-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drugCytotechnology, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Function and Regulation of the Human Multidrug Resistance GenePublished by Elsevier ,1992
- Multidrug Resistance and Chemosensitization: Therapeutic Implications for Cancer ChemotherapyPublished by Elsevier ,1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cellsBiochemical Pharmacology, 1988
- Localization of multidrug resistance-associated DNA sequences to human chromosome 7Somatic Cell and Molecular Genetics, 1986
- The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approachBritish Journal of Cancer, 1985
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Dependence of HL‐60 myeloid cell differentiation on continuous and split retinoic acid exposures: Precommitment memory associated with altered nuclear structureJournal of Cellular Physiology, 1984